---
figid: PMC11871742__13065_2025_1420_Fig1_HTML
figtitle: PI3K/Akt/mTOR signaling pathway
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11871742
filename: 13065_2025_1420_Fig1_HTML.jpg
figlink: /pmc/articles/PMC11871742/figure/F1/
number: F1
caption: Schematic diagram of the PI3K/Akt/mTOR signaling pathway. p85 regulatory
  subunit and p110 catalytic subunit can form p85-p110 complexes causing p110 to be
  in a resting state. SH2 domains of p85 permit complex to combine with phosphorylated
  tyrosine residues, which recover activity of p110. Gβγ subunits can activate PI3Kγ/β.
  Class I PI3Ks phosphorylate PIP2 to produce PIP3, which recruits Akt by binding
  to the pH domain. Then, Akt is phosphorylated at THR308 and SER473. Subsequently,
  downstream effectors are phosphorylated, leading to the cascade amplification of
  PI3K pathway
papertitle: In silico discovery of a novel potential allosteric PI3Kα inhibitor incorporating
  2-oxopropyl urea targeting head and neck squamous cell carcinoma
reftext: Wenqing Jia, et al. BMC Chem. 2025 Dec;19(1).
year: '2025'
doi: 10.1186/s13065-025-01420-6
journal_title: BMC Chemistry
journal_nlm_ta: BMC Chem
publisher_name: BMC
keywords: PIK3CA mutations | Allosteric PI3Kα inhibitors | STX-478 | Scaffold hopping
  | Molecular dynamics | Head and neck squamous cell carcinoma
automl_pathway: 0.9500541
figid_alias: PMC11871742__F1
figtype: Figure
redirect_from: /figures/PMC11871742__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11871742__13065_2025_1420_Fig1_HTML.html
  '@type': Dataset
  description: Schematic diagram of the PI3K/Akt/mTOR signaling pathway. p85 regulatory
    subunit and p110 catalytic subunit can form p85-p110 complexes causing p110 to
    be in a resting state. SH2 domains of p85 permit complex to combine with phosphorylated
    tyrosine residues, which recover activity of p110. Gβγ subunits can activate PI3Kγ/β.
    Class I PI3Ks phosphorylate PIP2 to produce PIP3, which recruits Akt by binding
    to the pH domain. Then, Akt is phosphorylated at THR308 and SER473. Subsequently,
    downstream effectors are phosphorylated, leading to the cascade amplification
    of PI3K pathway
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FZD4
  - NMUR1
  - LPAR3
  - LGR6
  - MRGPRX3
  - MRGPRX4
  - GPR151
  - OXER1
  - GPRC6A
  - MRGPRX1
  - VN1R17P
  - GPR166P
  - GRM1
  - GRM2
  - GRM3
  - GRM4
  - GRM5
  - GRM6
  - GRM7
  - GRM8
  - CASR
  - GABBR1
  - GABBR2
  - GPR156
  - GPR158
  - GPR179
  - GPRC5A
  - GPRC5B
  - GPRC5C
  - GPRC5D
  - PTEN
  - THOC1
  - PPP1R12C
  - SIRPA
  - PIK3R5
  - PDK1
  - PDPK1
  - PIK3R1
  - PIK3R2
  - ARHGEF7
  - CBFA2T2
  - PPP1R13B
  - AKT1
  - AKT2
  - AKT3
  - PIK3CA
  - MTOR
  - RPTOR
  - RPS6KB1
  - RPS6KB2
  - MAPKAP1
  - RICTOR
  - MLST8
---
